华东医药(000963.SZ)发布前三季度业绩，归母净利润27.48亿元，同比增长7.24%

Core Insights - The company reported a revenue of 32.664 billion yuan for the first three quarters of 2025, representing a year-on-year growth of 3.77% [1] - The net profit attributable to shareholders of the listed company reached 2.748 billion yuan, with a year-on-year increase of 7.24% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 2.694 billion yuan, showing a year-on-year growth of 8.53% [1]